---
figid: PMC9599866__cancers-14-04982-g003
pmcid: PMC9599866
image_filename: cancers-14-04982-g003.jpg
figure_link: /pmc/articles/PMC9599866/figure/cancers-14-04982-f003/
number: Figure 3
figure_title: ''
caption: 'Schematic representation of the RAS signaling pathway and relevant targets
  for combination therapy regimens. T symbol in red: therapeutic targets combined
  with KRAS G12 inhibitors in clinical trials (). RTKs: receptor tyrosine kinases;
  AUKRA: aurora kinase A; FAK: focal adhesion kinase.'
article_title: 'Targeting KRAS in PDAC: A New Way to Cure It?.'
citation: Qianyu He, et al. Cancers (Basel). 2022 Oct;14(20):4982.
year: '2022'

doi: 10.3390/cancers14204982
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI

keywords:
- PDAC
- KRAS
- drug resistance
- autophagy
- combination therapy

---
